These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28930549)

  • 1. Growth factors in the pathogenesis of diabetic foot ulcers.
    Qi M; Zhou Q; Zeng W; Wu L; Zhao S; Chen W; Luo C; Shen M; Zhang J; Tang CE
    Front Biosci (Landmark Ed); 2018 Jan; 23(2):310-317. PubMed ID: 28930549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factors in the treatment of diabetic foot ulcers.
    Bennett SP; Griffiths GD; Schor AM; Leese GP; Schor SL
    Br J Surg; 2003 Feb; 90(2):133-46. PubMed ID: 12555288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human epidermal growth factor enhances healing of diabetic foot ulcers.
    Tsang MW; Wong WK; Hung CS; Lai KM; Tang W; Cheung EY; Kam G; Leung L; Chan CW; Chu CM; Lam EK
    Diabetes Care; 2003 Jun; 26(6):1856-61. PubMed ID: 12766123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Diabetic Wound-Healing Outcomes With Topical Growth Factor Therapies.
    Wong AYW; Hooi NMF; Yeo BSY; Sultana R; Bee YM; Lee ARYB; Tay SM
    J Clin Endocrinol Metab; 2024 Jul; 109(8):e1642-e1651. PubMed ID: 38477463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heberprot-P's Effect on Gene Expression in Healing Diabetic Foot Ulcers.
    Camacho-Rodríguez H; Guillen-Pérez IA; Roca-Campaña J; Baldomero-Hernández JE; Tuero-Iglesias ÁD; Galván-Cabrera JA; Rodriguez-Cordero M; Palenzuela-Gardón DO; Berlanga-Acosta J; Novoa-Pérez LI
    MEDICC Rev; 2018 Jul; 20(3):10-14. PubMed ID: 31242156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factors in the treatment of diabetic foot ulcers: new technologies, any promises?
    Papanas N; Maltezos E
    Int J Low Extrem Wounds; 2007 Mar; 6(1):37-53. PubMed ID: 17344201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human epidermal growth factor (REGEN-D 150): effect on healing of diabetic foot ulcers.
    Mohan VK
    Diabetes Res Clin Pract; 2007 Dec; 78(3):405-11. PubMed ID: 17655964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review.
    Zubair M; Ahmad J
    Rev Endocr Metab Disord; 2019 Jun; 20(2):207-217. PubMed ID: 30937614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical Recombinant Human Epidermal Growth Factor for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Controlled Clinical Trials.
    Yang Q; Zhang Y; Yin H; Lu Y
    Ann Vasc Surg; 2020 Jan; 62():442-451. PubMed ID: 31394225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers.
    Richard JL; Sotto A; Jourdan N; Combescure C; Vannereau D; Rodier M; Lavigne JP;
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):363-9. PubMed ID: 18632297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Long-Term Outcomes Following the Application of Intralesional Epidermal Growth Factor in Patients With Diabetic Foot Ulcers.
    Kahraman M; Misir A; Kizkapan TB; Ozcamdalli M; Uzun E; Mutlu M
    J Foot Ankle Surg; 2019 Mar; 58(2):282-287. PubMed ID: 30612874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of neuropathy and plasma nitric oxide in recurrent neuropathic and neuroischemic diabetic foot ulcers.
    Jude EB; Tentolouris N; Appleton I; Anderson S; Boulton AJ
    Wound Repair Regen; 2001; 9(5):353-9. PubMed ID: 11896978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction.
    Ojalvo AG; Acosta JB; Marí YM; Mayola MF; Pérez CV; Gutiérrez WS; Marichal II; Seijas EÁ; Kautzman AM; Pacheco AE; Armstrong DG
    Int Wound J; 2017 Feb; 14(1):214-225. PubMed ID: 27002919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial.
    Park KH; Han SH; Hong JP; Han SK; Lee DH; Kim BS; Ahn JH; Lee JW
    Diabetes Res Clin Pract; 2018 Aug; 142():335-344. PubMed ID: 29902542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Recombinant Proteins and Growth Factors in the Management of Diabetic Foot Ulcers: A Systematic Review of Randomized Controlled Trials.
    Mahdipour E; Sahebkar A
    J Diabetes Res; 2020; 2020():6320514. PubMed ID: 32733969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the action mechanism of the peptide compounds of Wuguchong on diabetic ulcers, based on UHPLC-Q-TOF-MS, network pharmacology and experimental validation.
    Taowen P; Shuyuan F; Xiaoli S; Annan W; Feng Q; Yizhong Z; Jing L; Bin L; Kun L; Yunpeng D
    J Ethnopharmacol; 2022 Apr; 288():114974. PubMed ID: 35033625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal Growth Factor is Effective in the Treatment of Diabetic Foot Ulcers: Meta-Analysis and Systematic Review.
    Bui TQ; Bui QVP; Németh D; Hegyi P; Szakács Z; Rumbus Z; Tóth B; Emri G; Párniczky A; Sarlós P; Varga O
    Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31331038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor in the treatment of diabetic foot ulcers: an update.
    Tiaka EK; Papanas N; Manolakis AC; Georgiadis GS
    Perspect Vasc Surg Endovasc Ther; 2012 Mar; 24(1):37-44. PubMed ID: 22494968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal Growth Factor in Healing Diabetic Foot Ulcers: From Gene Expression to Tissue Healing and Systemic Biomarker Circulation.
    Berlanga-Acosta J; Camacho-Rodríguez H; Mendoza-Marí Y; Falcón-Cama V; García-Ojalvo A; Herrera-Martínez L; Guillén-Nieto G
    MEDICC Rev; 2020 Jul; 22(3):24-31. PubMed ID: 32812896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose erythropoietin promotes wound-healing of ulcers in diabetics: Evidence from a phase-IIa clinical study.
    Chatzikyrkou C; Bahlmann FH; Sushakova N; Scurt FG; Menne J; Nawroth P; Mertens PR; Haller H
    Diabetes Metab; 2016 Dec; 42(6):466-470. PubMed ID: 27324461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.